NSE › Healthcare

Fredun Pharmaceuticals Limited (FREDUN)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹1,472.60-1.63%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

₹228 cr

Revenue YoY

+90.7%

Net profit

₹13 cr

Profit YoY

+94.1%

Net margin

5.8%

Key statistics

Market cap

₹2,335 cr

P/E

49.7

Forward P/E

0.0

P/B

8.29

Book value

₹169.39

EPS (TTM)

₹27.53

52-week high

₹1,665.00

52-week low

₹1,195.20

50-day MA

₹1,420.13

200-day MA

₹1,421.57

Beta

0.86

Shareholding

Promoters

53.89%

Institutions

0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Fredun Pharmaceuticals Limited — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Laurus Labs Limited Lenskart Solutions Ltd Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Dr. Reddy's Laboratories Limited Cipla Limited Mankind Pharma Ltd Aurobindo Pharma Limited Lupin Limited

Data updated 2026-11-07.